These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 6103055)

  • 1. p-Methoxyamphetamine, a potent reversible inhibitor of type-A monoamine oxidase in vitro and in vivo.
    Green AL; El Hait MA
    J Pharm Pharmacol; 1980 Apr; 32(4):262-6. PubMed ID: 6103055
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A new approach to the assessment of the potency of reversible monoamine oxidase inhibitors in vivo, and its application to (+)-amphetamine, p-methoxyamphetamine and harmaline.
    Green AL; El Hait MA
    Biochem Pharmacol; 1980 Oct; 29(20):2781-9. PubMed ID: 6893669
    [No Abstract]   [Full Text] [Related]  

  • 3. Monoamine oxidase-inhibiting properties of SR 95191, a new pyridazine derivative, in the rat: evidence for selective and reversible inhibition of monoamine oxidase type A in vivo but not in vitro.
    Kan JP; Steinberg R; Leclercq J; Worms P; Biziere K
    J Neurochem; 1988 Apr; 50(4):1137-44. PubMed ID: 3346672
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The effects of phenelzine and other monoamine oxidase inhibitor antidepressants on brain and liver I2 imidazoline-preferring receptors.
    Alemany R; Olmos G; García-Sevilla JA
    Br J Pharmacol; 1995 Feb; 114(4):837-45. PubMed ID: 7773544
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A comparison of the pharmacological and biochemical properties of substrate-selective monoamine oxidase inhibitors.
    Christmas AJ; Coulson CJ; Maxwell DR; Riddell D
    Br J Pharmacol; 1972 Jul; 45(3):490-503. PubMed ID: 5072232
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Selective inhibition by amiflamine of monoamine oxidase type A in rat brain, liver and duodenum.
    Ask AL
    Naunyn Schmiedebergs Arch Pharmacol; 1984 Aug; 327(1):56-63. PubMed ID: 6493351
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The nature of the inhibition of rat liver monoamine oxidase types A and B by the acetylenic inhibitors clorgyline, l-deprenyl and pargyline.
    Fowler CJ; Mantle TJ; Tipton KF
    Biochem Pharmacol; 1982 Nov; 31(22):3555-61. PubMed ID: 6817759
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Potentiation of 3,4-methylenedioxymethamphetamine-induced 5-HT release in the rat substantia nigra by clorgyline, a monoamine oxidase A inhibitor.
    Hewton R; Salem A; Irvine RJ
    Clin Exp Pharmacol Physiol; 2007 Oct; 34(10):1051-7. PubMed ID: 17714093
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A comparison of cardiac and vascular clorgyline-resistant amine oxidase and monoamine oxidase. Inhibition by amphetamine, mexiletine and other drugs.
    Clarke DE; Lyles GA; Callingham BA
    Biochem Pharmacol; 1982 Jan; 31(1):27-35. PubMed ID: 7059347
    [No Abstract]   [Full Text] [Related]  

  • 10. Characteristics and specificity of phenelzine and benserazide as inhibitors of benzylamine oxidase and monoamine oxidase.
    Andree TH; Clarke DE
    Biochem Pharmacol; 1982 Mar; 31(5):825-30. PubMed ID: 7082351
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Interaction between cytosolic monoamine oxidase and spin-labeled amphetamine and its modification by clorgyline and pargyline.
    Copeland ES; Campbell IC; Murphy DL
    Biochim Biophys Acta; 1983 Feb; 743(1):186-94. PubMed ID: 6824699
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The inhibition of monoamine oxidase by tricyclic antidepressants: the influence of the nature of the substrate and the source of the enzyme.
    Green AL; McGachy HA
    J Pharm Pharmacol; 1987 May; 39(5):392-4. PubMed ID: 2886590
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Stress reduces in vivo inhibition of monoamine oxidase by phenelzine in rat brain.
    Clow A; Glover V; Oxenkrug GF; Sandler M
    Neurosci Lett; 1989 Dec; 107(1-3):331-4. PubMed ID: 2616044
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inhibition of monoamine oxidase by amphetamine and related compounds.
    Mantle TJ; Tipton KF; Garrett NJ
    Biochem Pharmacol; 1976 Sep; 25(18):2073-7. PubMed ID: 985546
    [No Abstract]   [Full Text] [Related]  

  • 15. Selective inhibition of monoamine oxidase in monoaminergic neurons in the rat brain.
    Ask AL; Fagervall I; Ross SB
    Naunyn Schmiedebergs Arch Pharmacol; 1983 Sep; 324(2):79-87. PubMed ID: 6646243
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhibition of brain type A monoamine oxidase and 5-hydroxytryptamine uptake by two amphetamine metabolites, p-hydroxyamphetamine and p-hydroxynorephedrine.
    Arai Y; Kim SK; Kinemuchi H; Tadano T; Satoh SE; Satoh N; Kisara K
    J Neurochem; 1990 Aug; 55(2):403-8. PubMed ID: 2370545
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identification of type A monoamine oxidase in mouse and rabbit liver mitochondria.
    Suzuki O; Mizutani S; Katsumata Y; Oya M
    Experientia; 1981 Jan; 37(1):18-9. PubMed ID: 6781927
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inhibition of type A monoamine oxidase by coptisine in mouse brain.
    Ro JS; Lee SS; Lee KS; Lee MK
    Life Sci; 2001 Dec; 70(6):639-45. PubMed ID: 11833714
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Liver monoamine oxidase in the obese-hyperglycaemic (ob/ob) mouse.
    Tong JH; Limson-Zamora M; D'Iorio A; Bégin-Heick N
    Biochem J; 1979 Mar; 177(3):943-9. PubMed ID: 444212
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of monoamine oxidase inhibition by clorgyline, deprenil or tranylcypromine on 5-hydroxytryptamine concentrations in rat brain and hyperactivity following subsequent tryptophan administration.
    Green AR; Youdim MB
    Br J Pharmacol; 1975 Nov; 55(3):415-22. PubMed ID: 1203627
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.